Cytogenetic Remissions In High-Risk Myelodysplastic Syndrome: Results In 124 Patients Treated With Low-Dose 5-Aza-2 '-Deoxycytidine (Decitabine), A Dna Methylation Inhibitor.
Blood（2000）
Key words
dna methylation inhibitor,cytogenetic remissions,dna methylation,high-risk,low-dose
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined